Iskrov, G., Vasilev, G., Stefanov, R. What could gene therapies learn from orphan drugs’ post-regulatory approval access in the EU?,
, .
Iskrov, G., Vasilev, G., Stefanov, R. .
What could gene therapies learn from orphan drugs’ post-regulatory approval access in the EU?.
: , .
Iskrov, G., Vasilev, G., Stefanov, R. ()
What could gene therapies learn from orphan drugs’ post-regulatory approval access in the EU?,
:
Iskrov, G.,
Vasilev, G., &
Stefanov, R.
().
What could gene therapies learn from orphan drugs’ post-regulatory approval access in the EU?. Expert Opinion on Orphan Drugs; Expert Opinion on Orphan Drugs.